The social production of hepatitis C risk among injecting drug users: a qualitative synthesis.

BACKGROUND Intervention impact on reductions in hepatitis C virus (HCV) incidence among injecting drug users (IDUs) are modest. There is a need to explore how drug injectors' interpret HCV risk. AIMS To review English-language qualitative empirical studies of HCV risk among IDUs. METHODS Qualitative synthesis using a meta-ethnographic approach. Searching of eight electronic databases and reference lists identified manually papers in peer-reviewed journals since 2000. Only studies investigating IDU perspectives on HCV risk were included. Themes across studies were identified systematically and compared, leading to a synthesis of second- and third-order constructs. FINDINGS We included 31 papers, representing 24 studies among over 1000 IDUs. Seven themes were generated: risk ubiquity; relative viral risk; knowledge uncertainty; hygiene and the body; trust and intimacy; risk environment; and the individualization of risk responsibility. Evidence supports a perception of HCV as a risk accepted rather than avoided. HCV was perceived largely as socially accommodated and expected, and in relative terms to human immunodeficiency virus (HIV) as the 'master status' of viral dangers. Symbolic knowledge systems, rather than biomedical risk calculus, and especially narratives of hygiene and trust, played a primary role in shaping interpretations of HCV risk. Critical factors in the risk environment included policing, homelessness and gendered risk. CONCLUSIONS Appealing to risk calculus alone is insufficient. Interventions should build upon the salience of hygiene and trust narratives in HCV risk rationality, and foster community changes towards the perceived preventability of HCV. Structural interventions in harm reduction should target policing, homelessness and gendered risk.

[1]  D. Vlahov,et al.  Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. , 1993, Addiction.

[2]  H. Klee,et al.  Hepatitis C testing and injecting risk behaviour: the results of a UK based pilot study , 2004 .

[3]  T. Rhodes,et al.  The social structural production of HIV risk among injecting drug users. , 2005, Social science & medicine.

[4]  C. Treloar ‘You Sort of Switch Off’: Exploring Mindlessness in Injecting Drug Users’ Accounts of Blood , 2005, Journal of health psychology.

[5]  C. Treloar,et al.  Chronic Illness Experiences, Clinical Markers and Living with Hepatitis C , 2007, Journal of health psychology.

[6]  T. Rhodes,et al.  Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty. , 2004, Addiction.

[7]  E. Plumridge,et al.  Identity and the social construction of risk : injecting drug use , 1999 .

[8]  E. Southgate,et al.  What's in a virus? Folk understandings of hepatitis C infection and infectiousness among injecting drug users in Kings Cross, Sydney , 2005, International journal for equity in health.

[9]  N. Beeching,et al.  Understanding social stigma in women with hepatitis C. , 2004, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[10]  S. Fraser,et al.  Blood and bioidentity: ideas about self, boundaries and risk among blood donors and people living with hepatitis C. , 2004, Social science & medicine.

[11]  T. Rhodes,et al.  Beyond prevention? Injecting drug user narratives about hepatitis C , 2004 .

[12]  S. Fraser ‘It’s Your Life!’: Injecting Drug Users, Individual Responsibility and Hepatitis C Prevention , 2004, Health.

[13]  S. Gifford,et al.  The lived experience of men and women with hepatitis C: implications for support needs and health information. , 2004, Australian health review : a publication of the Australian Hospital Association.

[14]  J. Parry,et al.  Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study , 2004, BMJ : British Medical Journal.

[15]  J. Ellard 'There is no profile it is just everyone': the challenge of targeting hepatitis C education and prevention messages to the diversity of current and future injecting drug users. , 2007, The International journal on drug policy.

[16]  R. Garfein,et al.  Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. , 2002, American journal of epidemiology.

[17]  R. Garfein,et al.  Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. , 2007, Drug and alcohol dependence.

[18]  P. Bourgois,et al.  The Everyday Violence of Hepatitis C Among Young Women Who Inject Drugs in San Francisco. , 2004, Human organization.

[19]  D. D. Des Jarlais,et al.  Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas , 2006, AIDS.

[20]  E. Murphy,et al.  Qualitative research methods in health technology assessment: a review of the literature. , 1998, Health technology assessment.

[21]  N. Wright,et al.  Exploring risk perception and behaviour of homeless injecting drug users diagnosed with hepatitis C. , 2005, Health & social care in the community.

[22]  J. Kaldor,et al.  Estimating progression to cirrhosis in chronic hepatitis C virus infection , 2001, Hepatology.

[23]  Rohan Jayasuriya,et al.  Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. , 2006, Addiction.

[24]  Belinda Crockett,et al.  “Eyes Wide Shut”: Narratives of Women Living with Hepatitis C in Australia , 2004, Women & health.

[25]  D. Easton,et al.  Structural barriers and facilitators in HIV prevention: a review of international research , 2000, AIDS.

[26]  N. Crofts,et al.  A History of Peer-Based Drug-User Groups in Australia , 1995 .

[27]  Heather Miller,et al.  Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial , 1999, The Lancet.

[28]  Jenny Donovan,et al.  Evaluating meta-ethnography: a synthesis of qualitative research on lay experiences of diabetes and diabetes care. , 2003, Social science & medicine.

[29]  Edward A Belongia,et al.  National Institutes of Health Consensus Development Conference Statement: management of hepatitis B. , 2009, Annals of internal medicine.

[30]  P. Miller Scapegoating, self-confidence and risk comparison: The functionality of risk neutralisation and lay epidemiology by injecting drug users , 2005 .

[31]  Richard Curtis,et al.  Social capital or networks, negotiations, and norms? A neighborhood case study. , 2007, American journal of preventive medicine.

[32]  L. Copeland The drug user's identity and how it relates to Being Hepatitis C antibody positive: a qualitative study , 2004 .

[33]  T. Rhodes,et al.  Global estimates of prevalence of HCV infection among injecting drug users. , 2007, The International journal on drug policy.

[34]  Robert Dingwall,et al.  Accounts, interviews and observations , 1997 .

[35]  M. Alary,et al.  High hepatitis C virus prevalence and incidence among Canadian intravenous drug users , 2007, International journal of STD & AIDS.

[36]  E. Wood,et al.  The public health and social impacts of drug market enforcement: A review of the evidence , 2005 .

[37]  T. Rhodes Risk theory in epidemic times: sex, drugs and the social organisation of ‘risk behaviour’ , 1997 .

[38]  D. Gibson,et al.  Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users. , 2001, AIDS.

[39]  W. Edmunds,et al.  Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales , 2006, BMC infectious diseases.

[40]  J. Bruneau,et al.  Exploring the contingent reality of biomedicine: Injecting drug users, hepatitis C virus and risk , 2005 .

[41]  D. D. Des Jarlais,et al.  HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection. , 2007, The International journal on drug policy.

[42]  N. Wright,et al.  Impact of a positive hepatitis C diagnosis on homeless injecting drug users: a qualitative study. , 2005, The British journal of general practice : the journal of the Royal College of General Practitioners.

[43]  D. D. Des Jarlais,et al.  Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001 , 2005, AIDS.

[44]  B. Berkhout,et al.  Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users , 2007, European Journal of Epidemiology.

[45]  S. Fraser,et al.  Hepatitis C, blood and models of the body: New directions for public health , 2004 .

[46]  Matthew Hickman,et al.  Global overview of injecting drug use and HIV infection among injecting drug users , 2004, AIDS.

[47]  Lee F. Monaghan,et al.  Vocabularies of motive for illicit steroid use among bodybuilders. , 2002, Social science & medicine.

[48]  T. Rhodes,et al.  Hygiene and uncertainty in qualitative accounts of hepatitis C transmission among drug injectors in Serbia. , 2008, Social science & medicine.

[49]  T. Rhodes,et al.  Preventing hepatitis C: 'common sense', 'the bug' and other perspectives from the risk narratives of people who inject drugs. , 2004, Social science & medicine.

[50]  T. Rhodes,et al.  Trust, disruption and responsibility in accounts of injecting equipment sharing and hepatitis C risk , 2008 .

[51]  C. Treloar,et al.  Broadening discussions of "safe" in hepatitis C prevention: a close-up of swabbing in an analysis of video recordings of injecting practice. , 2008, The International journal on drug policy.

[52]  P Vickerman,et al.  Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study. , 2007, International journal of epidemiology.

[53]  C. Seale,et al.  Quality in Qualitative Research , 1999 .

[54]  B. Paterson,et al.  Living With the Stigma of Hepatitis C , 2008, Western journal of nursing research.

[55]  É. Roy,et al.  Hepatitis C meanings and preventive strategies among street-involved young injection drug users in Montréal. , 2007, The International journal on drug policy.

[56]  L. Maher,et al.  Có vay có tra (What goes around comes around): culture, risk and vulnerability to blood-borne viruses among ethnic Vietnamese injecting drug users. , 2008, Drug and alcohol review.

[57]  R. Coutinho,et al.  Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users , 2007, Addiction.

[58]  P. Bourgois,et al.  The moral economies of homeless heroin addicts: confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. , 1998, Substance use & misuse.

[59]  M. Busch,et al.  Hepatitis C virus seroconversion among young injection drug users: relationships and risks. , 2002, The Journal of infectious diseases.

[60]  T. Wild,et al.  Everybody's got it, but...: situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada. , 2007, The International journal on drug policy.

[61]  D. D. Des Jarlais,et al.  Hepatitis C Virus Infection Among Injection Drug Users: Survival Analysis of Time to Seroconversion , 2004, Epidemiology.

[62]  T. Rhodes,et al.  Managing seen and unseen blood associated with drug injecting: implications for theorising harm reduction for viral risk , 2004 .

[63]  A. Wodak Injecting nation: achieving control of hepatitis C in Australia. , 1997, Drug and alcohol review.

[64]  P. Bourgois,et al.  Theory, method, and power in drug and HIV-prevention research: a participant-observer's critique. , 1999, Substance use & misuse.

[65]  S. Fraser,et al.  ‘Spoiled identity’ in hepatitis C infection: The binary logic of despair , 2006 .

[66]  K. Blankenship,et al.  Structural interventions in public health , 2000, AIDS.

[67]  T. Rhodes,et al.  Accounting for unprotected sex: stories of agency and acceptability. , 2002, Social science & medicine.

[68]  A. Wodak,et al.  Effectiveness of sterile needle and syringe programmes , 2005 .

[69]  C. Treloar,et al.  Information exchange among injecting drug users: a role for an expanded peer education workforce , 2005 .

[70]  D. Goldberg,et al.  Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature , 2002, Epidemiology and Infection.

[71]  S. Fraser,et al.  Putting at risk what we know: reflecting on the drug-using subject in harm reduction and its political implications. , 2006, Social science & medicine.

[72]  M. MacDonald,et al.  Transmission of hepatitis C virus: rates, routes, and cofactors. , 1996, Epidemiologic reviews.